Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Socie

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
High number of memory t cells is associated with higher risk of acute graft-versus-host disease after allogeneic stem cell transplantationMichael Loschi, Raphael Porcher, Regis Peffault de Latour, et al.
Blood|October 4, 2007
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working PartyDebra L Friedman, Alicia Rovo, Wendy Leisenring, et al.
Blood|October 8, 2010
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioningNavneet S Majhail, Ruta Brazauskas, J Douglas Rizzo, et al.
Blood|June 17, 2004
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationStephanie J Lee, Steven Joffe, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHDDaniel Wolff, Armin Gerbitz, Francis Ayuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2013
Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysisMadan Jagasia, Hildegard Greinix, Marie Robin, et al.
Blood|October 24, 2002
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantationVanderson Rocha, Rendrik F Franco, Raphael Porcher, et al.
Bone Marrow Transplantation|August 16, 2019
A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitorAlienor Xhaard, Manon Launay, Flore Sicre de Fontbrune, et al.
Haematologica|May 25, 2010
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working PartyAndrea Bacigalupo, Gerard Socie', Edoardo Lanino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor typeErica D Warlick, Regis Peffault de Latour, Ryan Shanley, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2014
High number of memory t cells is associated with higher risk of acute graft-versus-host disease after allogeneic stem cell transplantationMichael Loschi, Raphael Porcher, Regis Peffault de Latour, et al.
Blood|October 4, 2007
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working PartyDebra L Friedman, Alicia Rovo, Wendy Leisenring, et al.
Blood|October 8, 2010
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioningNavneet S Majhail, Ruta Brazauskas, J Douglas Rizzo, et al.
Blood|June 17, 2004
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationStephanie J Lee, Steven Joffe, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHDDaniel Wolff, Armin Gerbitz, Francis Ayuk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 30, 2013
Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysisMadan Jagasia, Hildegard Greinix, Marie Robin, et al.
Blood|October 24, 2002
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantationVanderson Rocha, Rendrik F Franco, Raphael Porcher, et al.
Bone Marrow Transplantation|August 16, 2019
A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitorAlienor Xhaard, Manon Launay, Flore Sicre de Fontbrune, et al.
Haematologica|May 25, 2010
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working PartyAndrea Bacigalupo, Gerard Socie', Edoardo Lanino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia: similar outcomes regardless of donor typeErica D Warlick, Regis Peffault de Latour, Ryan Shanley, et al.
Pageof 8